Literature DB >> 24072658

Anxiety state affects information processing speed in patients with multiple sclerosis.

Benedetta Goretti1, R G Viterbo, E Portaccio, C Niccolai, B Hakiki, E Piscolla, P Iaffaldano, M Trojano, M P Amato.   

Abstract

The aim of this study was to investigate the impact of anxiety on the cognitive performance of a clinical sample of relapsing-remitting (RR) MS patients. One hundred ninety patients (140 females) were included in the study and assessed through the beck depression inventory, the state-trait anxiety inventory and the Rao's brief repeatable battery which assesses cognitive domains most frequently impaired in MS. As for neuropsychological performance, a total of 76 (40%) subjects fulfilled our criterion for cognitive impairment. Tests most frequently failed by cognitive impairment (CI) patients were those assessing complex attention and information processing speed [Simbol Digit Modalities Test (SDMT), Paced Auditory Serial Auditory Test (PASAT) 3 and 2] and verbal memory. In the univariate analysis, state anxiety was related to failure on the SDMT (p = 0.042), and marginally, to failure on the PASAT-3 (p = 0.068), and to the presence of CI (p = 0.082). Moderate/severe depression was detected in 38 (20%) patients and fatigue in 109 (57%). Higher depression scores were related to impairment on the ST (OR = 1.05; 95% CI 1.01-1.10; p = 0.029).

Entities:  

Mesh:

Year:  2013        PMID: 24072658     DOI: 10.1007/s10072-013-1544-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  24 in total

1.  A normative study on visual reaction times and two Stroop colour-word tests.

Authors:  R Barbarotto; M Laiacona; R Frosio; M Vecchio; A Farinato; E Capitani
Journal:  Ital J Neurol Sci       Date:  1998-06

2.  Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials.

Authors:  Ralph H B Benedict; Audrey Smerbeck; Rajavi Parikh; Jonathan Rodgers; Diego Cadavid; David Erlanger
Journal:  Mult Scler       Date:  2012-01-25       Impact factor: 6.312

3.  The relationship between self-reported executive performance and psychological characteristics in multiple sclerosis.

Authors:  K van der Hiele; N G A Spliethoff-Kamminga; R P Ruimschotel; H A M Middelkoop; L H Visser
Journal:  Eur J Neurol       Date:  2011-10-18       Impact factor: 6.089

4.  A systematic meta-analysis of the Stroop task in depression.

Authors:  Amanda M Epp; Keith S Dobson; David J A Dozois; Paul A Frewen
Journal:  Clin Psychol Rev       Date:  2012-02-28

5.  The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population.

Authors:  M P Amato; E Portaccio; B Goretti; V Zipoli; L Ricchiuti; M F De Caro; F Patti; R Vecchio; S Sorbi; M Trojano
Journal:  Mult Scler       Date:  2006-12       Impact factor: 6.312

Review 6.  Cognitive changes in multiple sclerosis.

Authors:  Maria Pia Amato; Valentina Zipoli; Emilio Portaccio
Journal:  Expert Rev Neurother       Date:  2008-10       Impact factor: 4.618

7.  Factors affecting anxiety in multiple sclerosis.

Authors:  A C Garfield; N B Lincoln
Journal:  Disabil Rehabil       Date:  2012       Impact factor: 3.033

8.  Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.

Authors:  B Brochet; M S A Deloire; M Bonnet; E Salort-Campana; J C Ouallet; K G Petry; V Dousset
Journal:  Mult Scler       Date:  2008-07-24       Impact factor: 6.312

9.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

10.  A large-scale study of anxiety and depression in people with Multiple Sclerosis: a survey via the web portal of the UK MS Register.

Authors:  Kerina H Jones; David V Ford; Philip A Jones; Ann John; Rodden M Middleton; Hazel Lockhart-Jones; Lisa A Osborne; J Gareth Noble
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more
  14 in total

1.  Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients.

Authors:  Seyed-Parsa Hojjat; Charles Grady Cantrell; Rita Vitorino; Anthony Feinstein; Zahra Shirzadi; Bradley J MacIntosh; David E Crane; Lying Zhang; Sarah A Morrow; Liesly Lee; Paul O'Connor; Timothy J Carroll; Richard I Aviv
Journal:  Mult Scler       Date:  2016-01-11       Impact factor: 6.312

2.  The computer-based Symbol Digit Modalities Test: establishing age-expected performance in healthy controls and evaluation of pediatric MS patients.

Authors:  Sandra Bigi; R A Marrie; C Till; E A Yeh; N Akbar; A Feinstein; B L Banwell
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

3.  Cognitive assessment in multiple sclerosis-an Italian consensus.

Authors:  Maria Pia Amato; Vincenzo Brescia Morra; Monica Falautano; Angelo Ghezzi; Benedetta Goretti; Francesco Patti; Alice Riccardi; Flavia Mattioli
Journal:  Neurol Sci       Date:  2018-05-15       Impact factor: 3.307

Review 4.  Psychiatric disorders in multiple sclerosis.

Authors:  Maddalena Sparaco; Luigi Lavorgna; Simona Bonavita
Journal:  J Neurol       Date:  2019-06-13       Impact factor: 4.849

Review 5.  Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder.

Authors:  Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Meghan Beier; Jodie K Haselkorn; Alicia P Sloan; Dawn M Ehde
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

Review 6.  The link between multiple sclerosis and depression.

Authors:  Anthony Feinstein; Sandra Magalhaes; Jean-Francois Richard; Blair Audet; Craig Moore
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

Review 7.  Comorbidity in multiple sclerosis: implications for patient care.

Authors:  Ruth Ann Marrie
Journal:  Nat Rev Neurol       Date:  2017-03-17       Impact factor: 42.937

8.  Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.

Authors:  Stella Célio Junqueira; Igor Dos Santos Coelho; Vicente Lieberknecht; Mauricio Peña Cunha; João B Calixto; Ana Lúcia S Rodrigues; Adair Roberto Soares Santos; Rafael Cypriano Dutra
Journal:  Mol Neurobiol       Date:  2016-04-30       Impact factor: 5.590

9.  Relationship Between Anxiety and Cognition in Multiple Sclerosis: Implications for Treatment.

Authors:  Nicholas A Vissicchio; Caroline Altaras; Amanda Parker; Shonna Schneider; Jeffrey G Portnoy; Roseanne Archetti; Marnina Stimmel; Frederick W Foley
Journal:  Int J MS Care       Date:  2019 Jul-Aug

10.  Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders.

Authors:  Ruth Ann Marrie; Ronak Patel; Charles N Bernstein; James M Bolton; Lesley A Graff; James J Marriott; Carol A Hitchon; Chase R Figley; Jennifer Kornelsen; John D Fisk
Journal:  Mult Scler       Date:  2020-09-25       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.